Archives of Microbiology (2021) 203:1451–1459
1453
Oil; Yield 80%; Anal. Calc. For C10H17NO: C
71.81, H 10.25, N 8.37%; found: C 71.79, H 10.26, N
8.39%; IR maxcm−1: 3250 (NO–H), 2864 (C–H), 1632
(C = N), 936 (N–O stretch); 1H NMR (DMSO-d6)
(ppm): 8.95 (s, 1H, N–OH), 7.81 (s, 1H, CH = N–OH),
6.01 (d, 1H, = CH–CH=N, J = 11.7 Hz), 5.13–5.09 (t,
1H,=CH–CH2), 2.36–2.32 (t, 2H, CH2-CH2), 2.14–2.11 (t,
2H, CH2–CH2), 1.81 (s, 3H, CH3), 1.65 (s, 3H, CH3), 1.61
(s, 3H, CH3); 13CNMR (DMSO-d6) (ppm): 146.2 (C=N),
144.9, 132.2, 123.4, 121.7, 39.2, 26.2, 24.6, 21.2, 19.8;
ESI–MS m/z: [M+ +1] 168.15.
(s, 3H, CH3);13CNMR (DMSO-d6) d(ppm): 179.9, 144.1,
141.6, 132.2, 123.4, 121.9, 39.4, 26.5, 24.9, 19.8, 17.9;
ESI–MS m/z: [M+ +1] 226.15.
Bacterial strain and growth conditions
An existing stock culture of Chromobacterium violaceum
ATCC12472 stored at -80 °C supplemented with 20% glyc-
erol in the Department of Clinical Microbiology and Infec-
tious Diseases, University of the Witwatersrand, Johannes-
burg, was used in this study. For experimental purpose, the
bacterial culture was revived by growing in Luria–Bertani
(LB) agar plates at 30 °C for 24 h. All culture media and
other chemicals used in this study are of high analytical
grade.
3,7‑dimethylocta‑2,6‑dien‑1‑ylidene)
hydrazine‑1‑carboxamide (CD2)
Citral (1 eq) was mixed with semicarbazide (1 eq) in ethanol
with few drops of 10% NaOH under refux for 5 h. Comple-
tion of the reaction was monitored by TLC. After comple-
tion of the reaction, the organic layer was extracted, washed,
dried with NaSO4 and evaporated under vacuo.
Antimicrobial susceptibility testing
To determine the antibacterial activity of citral and its newly
synthesised derivatives, minimum inhibitory concentration
(MIC) for C. violaceum ATCC12472 was determined by
broth microdilution susceptibility testing as per the recom-
mended guidelines of Clinical and Laboratory Standards
Laboratory Standards Institute 2015). The stock solutions of
250 µg/ml all the test compounds were prepared using 1%
dimethyl sulfoxide (DMSO) and the range of concentrations
tested was 62.5–0.031 µg/ml. In every set of experiment, cell
free (sterility) and compound free (growth) controls were
included. The MICs were defned as the lowest concentra-
tion of test compounds that resulted in the inhibition of vis-
ible growth. Results were calculated as a mean of experi-
ments performed in triplicate.
Yield 75%; Anal. Calc. For C11H19N3O: C 63.13, H 9.15,
N 20.08%; found: C 63.25, H 9.20, N 20.25%; IR νmaxcm−1:
3550, (NH), 3360, 3180 (NH2), 3010 (C–H) 1530 (C=N),
1650 (C=C), 1165 (C–N), 1085 (C=O); 1H NMR (DMSO-
d6) d(ppm): 9.26 (1H, s, −NH), 6.95 (1H, d, –CH=N,
8.0 Hz), 6.90 (s, 2H, NH2), 5.97 (d, 1H, − CH, 4.0 Hz),
5.13–5.09 (t, 1H,=CH–CH2), 2.36–2.32 (t, 2H, CH2–CH2),
2.15–2.11 (t, 2H, CH2–CH2), 1.81 (s, 3H, CH3), 1.64 (s,
3H, CH3), 1.61 (s, 3H, CH3); 13CNMR (DMSO-d6) d(ppm):
156.9, 144.0, 141.8, 132.2, 123.4, 122.0, 39.4, 26.2, 24.9,
19.8, 17.9; ESI–MS m/z: [M+ +1] 210.20.
3,7‑dimethylocta‑2,6‑dien‑1‑ylidene)
hydrazinecarbothioamide (CD3)
Antiquorum sensing activity
Qualitative evaluation of antiquorum activity in C.
Citral (1 eq) was mixed with thiosemicarbazide (1 eq) in
ethanol with few drops of 10% NaOH under refux for 5 h.
Completion of the reaction was monitored by TLC. After
completion of the reaction, the organic layer was extracted,
washed, dried with NaSO4 and evaporated under vacuo.
Yield 75%; Anal. Calc. For C11H19N3S: C 58.63, H 8.50,
N 18.65%; found: C 58.85, H 8.20, N 18.85%; IR νmaxcm−1:
3545, (NH), 3386, 3180 (NH2), 3021 (C–H) 1534 (C=N),
1650 (C=C), 1168 (C–N), 1080 (C=S); 1H NMR (DMSO-
d6) d(ppm): 9.32 (1H, s, − NH), 8.84 (s, 2H, NH2), 7.29
(1H, d, –CH=N, 8.0 Hz), 5.98 (d, 1H, − CH, 8.0 Hz), 5.13
(t, 1H,=CH–CH2), 2.36–2.33 (t, 2H, CH2–CH2), 2.15–2.11
(t, 2H, CH2–CH2), 1.82 (s, 3H, CH3), 1.64 (s, 3H, CH3), 1.61
violaceum
Citral and its three newly synthesised derivatives
(CD1–CD3) were screened for their antiquorum activity by
qualitatively measuring the violacein pigment production by
biosensor strain C. violaceum ATCC12472, following the
method described previously (Ahmad et al. 2015a). Briefy,
sion was mixed with molten LB agar at 45 ºC and gently
poured into petri dishes and allowed to solidify. Sterile flter
discs (Mast Diagnostics, Merseyside, UK) infused with 20 µl
(MIC) of each test compound were placed on solid agar and
incubated at 30 °C for 18 h. Sterile disc impregnated with
1 3